SGLT2 inhibitor oncology research expands as clinical proof remains uneven
A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...
A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine